GlaxoSmithKlineE Dividend
Dividend criteria checks 2/6
GlaxoSmithKlineE is a dividend paying company with a current yield of 2.65%.
Key information
2.7%
Dividend yield
166%
Payout ratio
Industry average yield | 3.1% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | ج.م0.750 |
Earnings per share | ج.م0.45 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, BIOC has been paying a dividend for less than 10 years.
Growing Dividend: BIOC's dividend payments have increased, but the company has only paid a dividend for 7 years.
Dividend Yield vs Market
GlaxoSmithKlineE Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (BIOC) | 2.7% |
Market Bottom 25% (EG) | 2.5% |
Market Top 25% (EG) | 7.2% |
Industry Average (Pharmaceuticals) | 3.1% |
Analyst forecast in 3 Years (BIOC) | n/a |
Notable Dividend: BIOC's dividend (2.65%) is higher than the bottom 25% of dividend payers in the EG market (2.5%).
High Dividend: BIOC's dividend (2.65%) is low compared to the top 25% of dividend payers in the EG market (7.16%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (166.3%), BIOC's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (20.3%), BIOC's dividend payments are well covered by cash flows.